Literature DB >> 12956063

Synthesis of potent beta-secretase inhibitors containing a hydroxyethylamine dipeptide isostere and their structure-activity relationship studies.

Hirokazu Tamamura1, Terukazu Kato, Akira Otaka, Nobutaka Fujii.   

Abstract

Several beta-secretase inhibitors were designed based on hydroxyethylamine dipeptide isostere (HDI) structures and were synthesized by a methodology using the aza-Payne rearragement and O,N-acyl transfer reactions to study their structure-activity relationships. Among these pseudopeptides, effective compounds were developed as the first beta-secretase inhibitors containing the HDI transition state mimic with potent enzyme inhibitory activity (IC50 < 100 nM).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956063     DOI: 10.1039/b304842j

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  5 in total

Review 1.  Inhibition of BACE1 for therapeutic use in Alzheimer's disease.

Authors:  Xiaoyang Luo; Riqiang Yan
Journal:  Int J Clin Exp Pathol       Date:  2010-07-08

2.  BACE1 Inhibitor Peptides: Can an Infinitely Small k cat Value Turn the Substrate of an Enzyme into Its Inhibitor?

Authors:  Yoshio Hamada; Shoichi Ishiura; Yoshiaki Kiso
Journal:  ACS Med Chem Lett       Date:  2011-12-26       Impact factor: 4.345

3.  Functionalization of α-hydroxyphosphonates as a convenient route to N-tosyl-α-aminophosphonates.

Authors:  Tomasz Cytlak; Monika Skibińska; Patrycja Kaczmarek; Marcin Kaźmierczak; Magdalena Rapp; Maciej Kubicki; Henryk Koroniak
Journal:  RSC Adv       Date:  2018-03-27       Impact factor: 4.036

Review 4.  BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease.

Authors:  Arun K Ghosh; Heather L Osswald
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

Review 5.  Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs.

Authors:  Riqiang Yan
Journal:  Transl Neurodegener       Date:  2016-07-14       Impact factor: 8.014

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.